Table 4.
Treatment recommendations endorsed by participants for each condition.
| BED/obesity participants who endorsed treatment option n = 79 | Obesity-only participants who endorsed treatment option n = 96 | ||||
|---|---|---|---|---|---|
| Treatment | n (%) | n (%) | χ2 | p | Phi |
| Psychodynamic Therapy | 22 (27.8) | 14 (14.6) | 4.67 | 0.04 | 0.16 |
| Behavioral Weight Loss | 23 (29.1) | 85 (88.5) | 64.78 | <0.001 | 0.61 |
| Selective Serotonin Reuptake Inhibitors (SSRIs) | 30 (38) | 1 (1) | 40.56 | <0.001 | 0.48 |
| Tricyclic Antidepressants | 3 (1.3) | 0 (0) | 3.71 | 0.09 | 0.15 |
| Anticonvulsant Medication | 1 (1.3) | 1 (1) | 0.02 | 1.00 | 0.01 |
| Cognitive Analytic Therapy (CAT) | 7 (8.9) | 6 (6.3) | 0.43 | 0.57 | 0.05 |
| Dialectic Behavioral Therapy (DBT) | 14 (17.7) | 6 (6.3) | 5.63 | 0.03 | 0.18 |
| Cognitive Behavioral Therapy (CBT) | 69 (87.3) | 54 (56.3) | 20.06 | <0.001 | 0.34 |
| Eye movement desensitization and reprocessing | 2 (2.5) | 0 (0) | – | ||
| Short Term Benzodiazepines | 0 (0) | 0 (0) | – | ||
| Interpersonal Psychotherapy | 24 (30.4) | 12 (12.5) | 8.48 | 0.01 | 0.22 |
| Very low energy diets | 3 (3.8) | 37 (38.5) | 38.50 | <0.001 | 0.47 |
| Weight loss medication | 2 (2.5) | 27 (28.1) | 20.53 | <0.001 | 0.34 |
| Bariatric Surgery | 5 (6.3) | 51 (53.1) | 43.61 | <0.001 | 0.50 |
Bolded text denotes correct responses for each condition. Dash (–) indicates analysis not reported due to violation of assumption of ‘minimum expected cell frequency.’